Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by ELDRED KARY. Officer active across 1 company, notably Galectin Therapeutics INC. In total, 9 disclosures have been logged. Split: 9 buys · 0 sell. Total volume traded: €22k. Activity tracked since 25 January 2023. The latest transaction was filed on 21 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.